US Stock MarketDetailed Quotes

FBLG FibroBiologics

Watchlist
  • 3.040
  • -0.140-4.40%
Close Nov 4 16:00 ET
  • 3.114
  • +0.074+2.43%
Post 20:02 ET
107.19MMarket Cap-5109P/E (TTM)

FibroBiologics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-19.82%-1.95M
-109.97%-4.28M
-57.43%-6.4M
-36.49%-1.6M
16.68%-1.14M
-1.63M
-2.04M
-188.37%-4.07M
-1.17M
-1.37M
Net income from continuing operations
141.55%898K
-250.31%-8.46M
-221.91%-16.49M
-537.60%-9.72M
-40.33%-2.19M
---2.16M
---2.42M
-223.70%-5.12M
---1.52M
---1.56M
Operating gains losses
-7,163.16%-4.03M
20,593.33%3.1M
--7.31M
--7.24M
--0
--57K
--15K
----
----
----
Depreciation and amortization
41.41%140K
42.71%137K
364.89%437K
38.30%130K
--112K
--99K
--96K
--94K
--94K
--0
Other non cash items
----
----
-79.18%81K
--0
--0
--3K
--78K
--389K
--135K
--136K
Change In working capital
752.11%463K
262.40%419K
60.59%493K
253.33%318K
8,500.00%504K
---71K
---258K
78.49%307K
--90K
---6K
-Change in receivables
----
--0
----
----
----
----
---275K
----
----
----
-Change in prepaid assets
1,300.00%228K
-3,450.00%-710K
-187.50%-7K
-131.03%-9K
170.69%41K
---19K
---20K
121.62%8K
--29K
---58K
-Change in payables and accrued expense
1,556.52%335K
523.86%1.23M
54.67%812K
3.77%275K
390.54%363K
---23K
--197K
125.32%525K
--265K
--74K
-Change in other current assets
--0
97.18%-2K
333.33%14K
556.25%105K
977.27%193K
---213K
---71K
75.00%-6K
--16K
---22K
-Change in other current liabilities
-9.89%-100K
-10.11%-98K
-48.18%-326K
75.91%-53K
---93K
---91K
---89K
---220K
---220K
--0
Cash from discontinued investing activities
Operating cash flow
-19.82%-1.95M
-109.97%-4.28M
-57.43%-6.4M
-36.49%-1.6M
16.68%-1.14M
---1.63M
---2.04M
-188.37%-4.07M
---1.17M
---1.37M
Investing cash flow
Cash flow from continuing investing activities
-175.00%-66K
85.71%-8K
-495K
-2K
-413K
-24K
-56K
0
0
0
Net PPE purchase and sale
-175.00%-66K
85.71%-8K
---495K
---2K
---413K
---24K
---56K
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
-175.00%-66K
85.71%-8K
---495K
---2K
---413K
---24K
---56K
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
89.96%-172K
-77.50%3.28M
132.79%13.79M
0
413.33%940K
-1.71M
14.57M
226.09%5.93M
2.15M
-300K
Net issuance payments of debt
-157.33%-172K
--459K
-92.05%300K
--0
--0
--300K
--0
147.54%3.78M
--0
---300K
Net common stock issuance
--0
--2.82M
----
----
----
--0
--0
----
----
----
Net preferred stock issuance
--0
--0
650.60%16.14M
--0
--940K
--10.31M
--4.89M
--2.15M
--2.15M
--0
Proceeds from stock option exercised by employees
----
--0
----
----
----
----
--10M
----
----
----
Net other financing activities
----
----
---2.65M
--0
--0
---2.32M
---323K
----
----
----
Cash from discontinued financing activities
Financing cash flow
89.96%-172K
-77.50%3.28M
132.79%13.79M
--0
413.33%940K
---1.71M
--14.57M
226.09%5.93M
--2.15M
---300K
Net cash flow
Beginning cash position
-44.65%8.16M
304.37%9.16M
456.76%2.27M
735.22%10.77M
284.91%11.38M
--14.74M
--2.27M
--407K
--1.29M
--2.96M
Current changes in cash
35.01%-2.19M
-108.06%-1.01M
271.01%6.9M
-264.07%-1.6M
63.29%-612K
---3.36M
--12.47M
356.76%1.86M
--977K
---1.67M
End cash Position
-47.50%5.97M
-44.65%8.16M
304.37%9.16M
304.37%9.16M
735.22%10.77M
--11.38M
--14.74M
456.76%2.27M
--2.27M
--1.29M
Free cash flow
-22.07%-2.01M
-104.73%-4.28M
-69.60%-6.9M
-36.66%-1.6M
-13.53%-1.55M
---1.65M
---2.09M
-188.37%-4.07M
---1.17M
---1.37M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -19.82%-1.95M-109.97%-4.28M-57.43%-6.4M-36.49%-1.6M16.68%-1.14M-1.63M-2.04M-188.37%-4.07M-1.17M-1.37M
Net income from continuing operations 141.55%898K-250.31%-8.46M-221.91%-16.49M-537.60%-9.72M-40.33%-2.19M---2.16M---2.42M-223.70%-5.12M---1.52M---1.56M
Operating gains losses -7,163.16%-4.03M20,593.33%3.1M--7.31M--7.24M--0--57K--15K------------
Depreciation and amortization 41.41%140K42.71%137K364.89%437K38.30%130K--112K--99K--96K--94K--94K--0
Other non cash items ---------79.18%81K--0--0--3K--78K--389K--135K--136K
Change In working capital 752.11%463K262.40%419K60.59%493K253.33%318K8,500.00%504K---71K---258K78.49%307K--90K---6K
-Change in receivables ------0-------------------275K------------
-Change in prepaid assets 1,300.00%228K-3,450.00%-710K-187.50%-7K-131.03%-9K170.69%41K---19K---20K121.62%8K--29K---58K
-Change in payables and accrued expense 1,556.52%335K523.86%1.23M54.67%812K3.77%275K390.54%363K---23K--197K125.32%525K--265K--74K
-Change in other current assets --097.18%-2K333.33%14K556.25%105K977.27%193K---213K---71K75.00%-6K--16K---22K
-Change in other current liabilities -9.89%-100K-10.11%-98K-48.18%-326K75.91%-53K---93K---91K---89K---220K---220K--0
Cash from discontinued investing activities
Operating cash flow -19.82%-1.95M-109.97%-4.28M-57.43%-6.4M-36.49%-1.6M16.68%-1.14M---1.63M---2.04M-188.37%-4.07M---1.17M---1.37M
Investing cash flow
Cash flow from continuing investing activities -175.00%-66K85.71%-8K-495K-2K-413K-24K-56K000
Net PPE purchase and sale -175.00%-66K85.71%-8K---495K---2K---413K---24K---56K--0--0--0
Cash from discontinued investing activities
Investing cash flow -175.00%-66K85.71%-8K---495K---2K---413K---24K---56K--0--0--0
Financing cash flow
Cash flow from continuing financing activities 89.96%-172K-77.50%3.28M132.79%13.79M0413.33%940K-1.71M14.57M226.09%5.93M2.15M-300K
Net issuance payments of debt -157.33%-172K--459K-92.05%300K--0--0--300K--0147.54%3.78M--0---300K
Net common stock issuance --0--2.82M--------------0--0------------
Net preferred stock issuance --0--0650.60%16.14M--0--940K--10.31M--4.89M--2.15M--2.15M--0
Proceeds from stock option exercised by employees ------0------------------10M------------
Net other financing activities -----------2.65M--0--0---2.32M---323K------------
Cash from discontinued financing activities
Financing cash flow 89.96%-172K-77.50%3.28M132.79%13.79M--0413.33%940K---1.71M--14.57M226.09%5.93M--2.15M---300K
Net cash flow
Beginning cash position -44.65%8.16M304.37%9.16M456.76%2.27M735.22%10.77M284.91%11.38M--14.74M--2.27M--407K--1.29M--2.96M
Current changes in cash 35.01%-2.19M-108.06%-1.01M271.01%6.9M-264.07%-1.6M63.29%-612K---3.36M--12.47M356.76%1.86M--977K---1.67M
End cash Position -47.50%5.97M-44.65%8.16M304.37%9.16M304.37%9.16M735.22%10.77M--11.38M--14.74M456.76%2.27M--2.27M--1.29M
Free cash flow -22.07%-2.01M-104.73%-4.28M-69.60%-6.9M-36.66%-1.6M-13.53%-1.55M---1.65M---2.09M-188.37%-4.07M---1.17M---1.37M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data